Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-18
DOI: 10.2147/ijn.s654409 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Fuzhuo Wang und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, F., Sun, Y., Chen, Y., Xu, J., Huang, Y., & He, G. (2026). Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design. International Journal of Nanomedicine, Volume 21, 1-18. https://doi.org/10.2147/ijn.s654409
Vancouver
Wang F, Sun Y, Chen Y, Xu J, Huang Y, He G. Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design. International Journal of Nanomedicine. 2026;Volume 21:1-18. doi:10.2147/ijn.s654409
BibTeX
@article{Wang2026,
author = {Wang, Fuzhuo and Sun, Yang and Chen, Yi and Xu, Jiashuang and Huang, Ye and He, Guangpeng},
title = {Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--18},
doi = {10.2147/ijn.s654409}
}
EUVIMED